scispace - formally typeset
M

Masaki Azuma

Researcher at Tokyo Institute of Technology

Publications -  416
Citations -  11943

Masaki Azuma is an academic researcher from Tokyo Institute of Technology. The author has contributed to research in topics: Perovskite (structure) & Crystal structure. The author has an hindex of 49, co-authored 377 publications receiving 10579 citations. Previous affiliations of Masaki Azuma include National Presto Industries & Kurashiki University of Science and the Arts.

Papers
More filters
Journal ArticleDOI

Crystal structure and dielectric and magnetic properties of BiCrO3 as a ferroelectromagnet

TL;DR: In this article, the structure of BiCrO 3 at room temperature is a highly distorted perovskite-type one with monoclinic C2 symmetry which is the same as that of the ferroelectric phase in BiMnO 3.
Journal ArticleDOI

Stem Cell Defects in ATM-Deficient Undifferentiated Spermatogonia through DNA Damage-Induced Cell-Cycle Arrest

TL;DR: Flow cytometric analysis revealed that this population is composed of Plzf-positive cells and exhibits quiescence and the side population phenotype, fulfilling general stem cell criteria, and ATM plays an essential role in maintenance of undifferentiated spermatogonia and their stem cell capacity by suppressing DNA damage-induced cell-cycle arrest.
Journal ArticleDOI

Coherence Factors in a High-Tc Cuprate Probed by Quasi-Particle Scattering Off Vortices

TL;DR: F Fourier-transform scanning tunneling spectroscopy is used to reveal a magnetic-field dependence in quasi-particle scattering interference patterns that is sensitive to the sign of the anisotropic gap, and provides insights into the nature of electron pairing as well as quasi- particle scattering processes in unconventional superconductors.
Journal ArticleDOI

Regulation of Reactive Oxygen Species by Atm Is Essential for Proper Response to DNA Double-Strand Breaks in Lymphocytes

TL;DR: Atm-mediated ROS regulation is essential for proper DNA recombination, preventing immunodeficiency, and lymphomagenesis, and in vivo administration of NAC to Atm−/− mice restored normal T cell development and inhibited aberrant V(D)J recombination.